Daniel D. Myers

Cellular IL-10 is more effective than viral IL-10 in decreasing venous thrombosis.

P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model.

P-selectin and leukocyte microparticles are associated with venous thrombogenesis.

Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall.

Murine thrombosis models.

Gender differences in deep venous thrombosis in a rat model: a preliminary study.

Inflammation-dependent thrombosis.

L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation.

Correspondence of ultrasound elasticity imaging to direct mechanical measurement in aging DVT in rats.

D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study.

Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis.

Attenuation of experimental aortic aneurysm formation in P-selectin knockout mice.

Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation.

Gangrenous Clostridium perfringens infection and subsequent wound management in a rhesus macaque (Macaca mulatta).

Mechanisms of venous thrombosis and resolution.

Microparticle surface protein are associated with experimental venous thrombosis: a preliminary study.

Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis.

Aging is associated with impaired thrombus resolution in a mouse model of stasis induced thrombosis.

Enoxaparin treatment of spontaneous deep vein thrombosis in a chronically catheterized rhesus macaque (Macaca mulatta).

P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis.

Proteomics of microparticles after deep venous thrombosis.

Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model.

Extracellular DNA traps promote thrombosis.

Interleukin-6: a potential target for post-thrombotic syndrome.

Noninvasive treatment of deep venous thrombosis using pulsed ultrasound cavitation therapy (histotripsy) in a porcine model.

Male mice have increased thrombotic potential: sex differences in a mouse model of venous thrombosis.

Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis.

Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.

Myeloid cell tissue factor does not contribute to venous thrombogenesis in an electrolytic injury model.

Inflammation and thrombosis: new insights.

Statins, inflammation and deep vein thrombosis: a systematic review.

Critical review of mouse models of venous thrombosis.

Nonhuman primate models of thrombosis.

Circulating and vein wall P-selectin promote venous thrombogenesis during aging in a rodent model.

The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse.

Prothrombotic effects of thrombolytic therapy in a rat (Rattus norvegicus) model of venous thrombolysis.

Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis.

Effects of analgesic use on inflammation and hematology in a murine model of venous thrombosis.

The role of galectin-3 and galectin-3-binding protein in venous thrombosis.

P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.

A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation.

Practice patterns of adjunctive therapy for venous leg ulcers.

1D-¹H-nuclear magnetic resonance metabolomics reveals age-related changes in metabolites associated with experimental venous thrombosis.

Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model.

E-selectin inhibition with GMI-1271 decreases venous thrombosis without profoundly affecting tail vein bleeding in a mouse model.

Analgesic Efficacy and Hematologic Effects of Robenacoxib in Mice.

Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology.

Safety Considerations When Working with Humanized Animals.

Rapid, Reproducible, Quantifiable NMR Metabolomics: Methanol and Methanol: Chloroform Precipitation for Removal of Macromolecules in Serum and Whole Blood.

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): Zone I Balloon Occlusion Time Affects Spinal Cord Injury in the Nonhuman Primate Model.

Use of GMI-1271, an E-selectin antagonist, in healthy subjects and in 2 patients with calf vein thrombosis.

E-selectin inhibitor is superior to low-molecular-weight heparin for the treatment of experimental venous thrombosis.

Evaluation of Efficacy of 2 Extended-release Bupivacaine Products in a Porcine Model of Incisional Pain.